Company / Interest Expense per Share
ROCKET PHARMACEUTICALS, INC. Interest Expense per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.02
FY2025
5-year range
$0.02 / $0.11
FY2021-FY2025
Trend
-14.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has declined for 3 consecutive years, from $0.11 in FY2022 to $0.02 in FY2025.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -30.6%.
Improved from $0.04 to $0.02 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -45.3%
- 5-Year CAGR
- -30.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- ROCKET PHARMACEUTICALS, INC.'s interest expense per share has declined for 3 consecutive years.
- In FY2025, interest expense per share decreased 14.1% year-over-year.
- Peak interest expense per share was recorded in FY2019.
- Lowest interest expense per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -14.1% |
| FY2024 | $0.02 | -45.2% |
| FY2023 | $0.04 | -65.2% |
| FY2022 | $0.11 | +10.6% |
| FY2021 | $0.10 | -11.4% |
| FY2020 | $0.11 | -17.6% |
| FY2019 | $0.13 | - |
| FY2018 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026